Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Wilhelm-Thomas Micu"'
Autor:
Ciprian Tomuleasa, Shigeo Fuji, Cristian Berce, Anca Onaciu, Sergiu Chira, Bobe Petrushev, Wilhelm-Thomas Micu, Vlad Moisoiu, Ciprian Osan, Catalin Constantinescu, Sergiu Pasca, Ancuta Jurj, Laura Pop, Ioana Berindan-Neagoe, Delia Dima, Shigehisa Kitano
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
Chimeric antigen receptor (CAR) T-cell technology has seen a rapid development over the last decade mostly due to the potential that these cells may have in treating malignant diseases. It is a generally accepted principle that very few therapeutic c
Externí odkaz:
https://doaj.org/article/25605d9c06744b72bba8e6a2bddc8a47
Autor:
Anna Vischer, Ciprian Tomuleasa, Bobe Petrushev, Horia Bumbea, Sergiu Pasca, Delia Dima, Ravnit Grewal, Sonia Cismas, Sonia Selicean, Mirela Marian, Vlad Moisoiu, Alina Tanase, Laura Pop, Anca Jurj, Ioana Berindan-Neagoe, Wilhelm-Thomas Micu, Cristina Selicean, Mihnea Zdrenghea, Kanza Arifeen, Carmen Aanei
Publikováno v:
Critical Reviews in Clinical Laboratory Sciences. 55:329-345
Chronic lymphocytic leukemia (CLL) is a malignancy defined by the accumulation of mature lymphocytes in the lymphoid tissues, bone marrow, and blood. Therapy for CLL is guided according to the Rai and Binet staging systems. Nevertheless, state-of-the
Autor:
Ciprian Tomuleasa, Bobe Petrushev, Catalin-Sorin Constantinescu, Ciprian Osan, Jianliang Shen, Wilhelm-Thomas Micu, Huming Li, Liren Qian, Sergiu Chira, Ioana Berindan-Neagoe, Tiberiu Tat, Sebastian Tranca, Cristian Berce, Anca Onaciu, Vlad Moisoiu, Sergiu P. Paşca, Delia Dima
Publikováno v:
Oncotarget. 9:16557-16572
// Tiberiu Tat 1, 2 , Huming Li 3 , Catalin-Sorin Constantinescu 1, 4 , Anca Onaciu 5 , Sergiu Chira 5 , Ciprian Osan 5 , Sergiu Pasca 5 , Bobe Petrushev 5 , Vlad Moisoiu 5 , Wilhelm-Thomas Micu 5 , Cristian Berce 6 , Sebastian Tranca 2 , Delia Dima
Autor:
Ciprian Osan, Anca Onaciu, Ioana Berindan-Neagoe, Catalin-Sorin Constantinescu, Cristian Berce, Jianliang Shen, Wilhelm-Thomas Micu, Huming Li, Vlad Moisoiu, Liren Qian, Sergiu Chira, Ciprian Tomuleasa, Bobe Petrushev, Sebastian Tranca, Delia Dima, Tiberiu Tat, Sergiu P. Paşca
Publikováno v:
Oncotarget
Chimeric antigen receptor-modified T cells (CAR-T cells) and donor lymphocyte infusion (DLI) are important protocols in lymphocyte engineering. CAR-T cells have emerged as a new modality for cancer immunotherapy due to their potential efficacy agains
Autor:
Alina Tanase, Nicolae Leopold, Minodora Desmirean, Dalma Deak, Wilhelm-Thomas Micu, Ioana Berindan-Neagoe, Alexandra Sacu, Horia Bumbea, Laura Pop, Romulus Tetean, Ancuta Jurj, Andrei Colita, Cristian Berce, Ciprian Tomuleasa, Bobe Petrushev, Adrian P. Trifa, Vlad Moisoiu, Mihnea Zdrenghea, Alin Moldovan, Angela Dascalescu, Sergiu Pasca, Rares Stiufiuc, Delia Dima, Ioana Frinc, Bogdan Fetica, Grigore Gafencu, Sonia Selicean, Emil Burzo
Even if considered a cumulative and not a proliferative CD5+ B-cell neoplasm, chronic lymphocytic leukemia (CLL) has a proliferation rate higher than that recognized earlier, especially in the lymphoid tissues. Some patients with CLL develop a clinic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37162a29abcc8f3d4265cc42f2f326f5
Autor:
Sonia Selicean, Daiana Cosmina Temian, Sanda Boca, Wilhelm-Thomas Micu, Cristian Berce, Vlad Moisoiu, Ioana Berindan-Neagoe, Simion Astilean, Grigore-Aristide Gafencu, Cornelia Braicu, Ciprian Tomuleasa, Bobe Petrushev, Laura Pop, Ancuta Jurj
Publikováno v:
Medical hypotheses. 109
Alopecia is a dermatological condition for which Janus kinase (JAK) inhibitors have recently emerged as potential therapy options, but with limited practical use because of the systemic side effects. The topical use of Ruxolitinib in alopecia univers